Webcasts of the EGAM 2015 plenary session are available for viewing
7 Apr 2015
The plenary session presented information on the evolving structure of the EORTC as well as the clinical research landscape and new forms of clinical research activities covering the full span from early clinical trials to survivorship. Exchanging views with other stakeholders and discussing the role of academia will be major highlights.
EGAM 2015 also marked a special celebration in honor of Françoise Meunier, Director General and her many significant contributions to the EORTC over the past two and a half decades.
Webcasts
General introduction, Roger Stupp
The patients perspectives and survival issues, Isabelle Lebrocquy
Cancer Management and Transatlantic cooperation, Richard Schilsky
The EORTC Charitable Trust, Diego du Monceau
EORTC future perspectives, Roger Stupp
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023